Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("DALEN, James E")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 67

  • Page / 3
Export

Selection :

  • and

Aspirin to prevent heart attack and stroke : What's the right dose?DALEN, James E.The American journal of medicine. 2006, Vol 119, Num 3, pp 198-202, issn 0002-9343, 5 p.Article

Should Patients with Venous Thromboembolism Be Screened for Thrombophilia?DALEN, James E.The American journal of medicine. 2008, Vol 121, Num 6, pp 458-463, issn 0002-9343, 6 p.Article

Aspirin resistance: Is it real? Is it clinically significant? : CardiologyDALEN, James E.The American journal of medicine. 2007, Vol 120, Num 1, pp 1-4, issn 0002-9343, 4 p.Article

Economy class syndrome: Too much flying or too much sitting?DALEN, James E.Archives of internal medicine (1960). 2003, Vol 163, Num 22, pp 2674-2676, issn 0003-9926, 3 p.Article

Pulmonary embolism: What have we learned since virchow? Natural history, pathophysiology, and diagnosisDALEN, James E.Chest. 2002, Vol 122, Num 4, pp 1440-1456, issn 0012-3692Article

ACCP conference on antithrombotic therapy, June 21, 1988DALEN, James E; HIRSH, Jack.Chest. 1989, Vol 95, Num 2, issn 0012-3692, A-D, 1S-168S [173 p.]Conference Proceedings

Is the Campaign to Prevent VTE in Hospitalized Patients Working?STEIN, Paul D; MATTA, Fadi; DALEN, James E et al.Chest (American College of Chest Physicians). 2011, Vol 139, Num 6, pp 1317-1321, issn 0012-3692, 5 p.Article

ACCP consensus conference on antithrombotic therapyDALEN, James E; HIRSH, Jack.Chest. 1995, Vol 108, Num 4, issn 0012-3692, 303 p., SUPConference Proceedings

ACCP Concensus Conference on Antithrombotic TherapyDALEN, James E; HIRSH, Jack.Chest. 1998, Vol 114, Num 5, issn 0012-3692, 335 p., SUPConference Proceedings

Medicolegal implications of the consensus conference, with special attention to the fifth antithrombotic therapy consensus conferenceMCINTYRE, K. M.Chest. 1998, Vol 114, Num 5, pp 742S-747S, issn 0012-3692, SUPConference Paper

Medicolegal implications of consensus statementsMCINTYRE, K. M.Chest. 1995, Vol 108, Num 4, pp 502S-505S, issn 0012-3692, SUPConference Paper

Clinicians' responses to direct-to-consumer advertising of prescription medicationsZACHRY, Woodie M; DALEN, James E; JACKSON, Terrence R et al.Archives of internal medicine (1960). 2003, Vol 163, Num 15, pp 1808-1812, issn 0003-9926, 5 p.Article

Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass graftsSTEIN, Paul D; DALEN, James E; GOLDMAN, Steven et al.Chest. 2001, Vol 119, Num 1, pp 278S-282S, issn 0012-3692, SUPArticle

Antithrombotic therapy in peripheral arterial occlusive diseaseJACKSON, M. R; CLAGETT, G. P.Chest. 1998, Vol 114, Num 5, pp 666S-682S, issn 0012-3692, SUPConference Paper

Antithrombotic therapy in childrenMICHELSON, A. D; BOVILL, E; ANDREW, M et al.Chest. 1995, Vol 108, Num 4, pp 506S-522S, issn 0012-3692, SUPConference Paper

Minor Injuries as a Risk Factor for Venous Thrombosis. CommentaryDALEN, James E; VAN STRALEN, Karlijn J; ROSENDAAL, Frits R et al.Archives of internal medicine (1960). 2008, Vol 168, Num 1, issn 0003-9926, 14-15, 21-26 [8 p.]Article

New antithrombotic agentsWEITZ, J. I; HIRSH, J.Chest. 1998, Vol 114, Num 5, pp 715S-727S, issn 0012-3692, SUPConference Paper

Antithrombotic therapy in peripheral arterial occlusive diseaseCLAGETT, G. P; KRUPSKI, W. C.Chest. 1995, Vol 108, Num 4, pp 431S-443S, issn 0012-3692, SUPConference Paper

Antithrombotic Therapy in Atrial Fibrillation : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)SINGER, Daniel E; ALBERS, Gregory W; DALEN, James E et al.Chest. 2008, Vol 133, Num 6, issn 0012-3692, 546.S-592.S, SUPArticle

Antithrombotic therapy in patients with mechanical and biological prosthetic heart valvesSTEIN, Paul D; ALPERT, Joseph S; BUSSEY, Henry I et al.Chest. 2001, Vol 119, Num 1, pp 220S-227S, issn 0012-3692, SUPArticle

Oral anticoagulants : Mechanism of action, clinical effectiveness, and optimal therapeutic rangeHIRSH, Jack; DALEN, James E; ANDERSON, David R et al.Chest. 2001, Vol 119, Num 1, pp 8S-21S, issn 0012-3692, SUPArticle

Antithrombotic therapy in valvular heart diseaseSALEM, D. N; LEVINE, H. J; PAUKER, S. G et al.Chest. 1998, Vol 114, Num 5, pp 590S-601S, issn 0012-3692, SUPConference Paper

Antithrombotic therapy in patients undergoing coronary angioplastyPOPMA, J. J; COLLER, B. S; OHMAN, E. M et al.Chest. 1995, Vol 108, Num 4, pp 486S-501S, issn 0012-3692, SUPConference Paper

Oral anticoagulants : mechanism of action, clinical effectiveness, and optimal therapeutic rangeHIRSH, J; DALEN, J. E; DEYKIN, D et al.Chest. 1995, Vol 108, Num 4, pp 231S-246S, issn 0012-3692, SUPConference Paper

Prevention of venous thromboembolismCLAGETT, G. P; ANDERSON, F. A; HEIT, J et al.Chest. 1995, Vol 108, Num 4, pp 312S-334S, issn 0012-3692, SUPConference Paper

  • Page / 3